USD 77.85
(2.1%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.48 Billion USD | -33.26% |
2022 | 2.23 Billion USD | -9.64% |
2021 | 2.46 Billion USD | 83.71% |
2020 | 1.34 Billion USD | -26.8% |
2019 | 1.83 Billion USD | 106.29% |
2018 | 890 Million USD | -24.7% |
2017 | 1.18 Billion USD | 12.81% |
2016 | 1.04 Billion USD | 3.17% |
2015 | 1.01 Billion USD | 2.93% |
2014 | 986.78 Million USD | 17.57% |
2013 | 839.3 Million USD | 4.21% |
2012 | 805.4 Million USD | -0.24% |
2011 | 807.36 Million USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | -100.0% |
2007 | 400 Million USD | 0.0% |
2006 | - USD | -100.0% |
2005 | 54 Thousand USD | 0.0% |
2004 | - USD | -100.0% |
2003 | 24.99 Million USD | -2.42% |
2002 | 25.62 Million USD | 4242.37% |
2001 | 590 Thousand USD | -33.46% |
2000 | 886.62 Thousand USD | 0.0% |
1999 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 1.49 Billion USD | 0.0% |
2024 Q1 | 1.49 Billion USD | 0.07% |
2024 Q3 | 2.6 Billion USD | 33.42% |
2023 Q1 | 2.23 Billion USD | 0.13% |
2023 FY | 1.48 Billion USD | -33.26% |
2023 Q2 | 2.21 Billion USD | -0.9% |
2023 Q3 | 2.18 Billion USD | -1.22% |
2023 Q4 | 1.48 Billion USD | -31.92% |
2022 Q1 | 2.04 Billion USD | -17.21% |
2022 Q4 | 2.23 Billion USD | 79.49% |
2022 Q3 | 1.24 Billion USD | -2.13% |
2022 FY | 2.23 Billion USD | -9.64% |
2022 Q2 | 1.27 Billion USD | -37.87% |
2021 Q2 | 2.38 Billion USD | 2.01% |
2021 Q4 | 2.46 Billion USD | -0.08% |
2021 Q1 | 2.33 Billion USD | 73.81% |
2021 FY | 2.46 Billion USD | 83.71% |
2021 Q3 | 2.47 Billion USD | 3.69% |
2020 Q3 | 1.34 Billion USD | 0.3% |
2020 Q1 | 1.34 Billion USD | -26.58% |
2020 Q2 | 1.34 Billion USD | -0.59% |
2020 Q4 | 1.34 Billion USD | 0.0% |
2020 FY | 1.34 Billion USD | -26.8% |
2019 FY | 1.83 Billion USD | 106.29% |
2019 Q4 | 1.83 Billion USD | 0.77% |
2019 Q1 | 1.83 Billion USD | 105.62% |
2019 Q2 | 1.81 Billion USD | -0.66% |
2019 Q3 | 1.82 Billion USD | 0.22% |
2018 Q3 | 860 Million USD | 18.95% |
2018 Q1 | 710 Million USD | -39.93% |
2018 Q2 | 723 Million USD | 1.83% |
2018 FY | 890 Million USD | -24.7% |
2018 Q4 | 890 Million USD | 3.49% |
2017 FY | 1.18 Billion USD | 12.81% |
2017 Q4 | 1.18 Billion USD | 0.17% |
2017 Q3 | 1.18 Billion USD | 0.94% |
2017 Q2 | 1.16 Billion USD | 10.81% |
2017 Q1 | 1.05 Billion USD | 0.69% |
2016 FY | 1.04 Billion USD | 3.17% |
2016 Q1 | 1.02 Billion USD | 0.69% |
2016 Q3 | 1.04 Billion USD | 0.91% |
2016 Q2 | 1.03 Billion USD | 0.85% |
2016 Q4 | 1.04 Billion USD | 0.68% |
2015 Q2 | 1 Billion USD | 0.71% |
2015 FY | 1.01 Billion USD | 2.93% |
2015 Q3 | 1 Billion USD | 0.71% |
2015 Q4 | 1.01 Billion USD | 0.77% |
2015 Q1 | 993.77 Million USD | 0.71% |
2014 Q4 | 986.78 Million USD | 0.71% |
2014 Q2 | 972.94 Million USD | 0.0% |
2014 Q3 | 979.83 Million USD | 0.71% |
2014 FY | 986.78 Million USD | 17.57% |
2014 Q1 | - USD | -100.0% |
2013 FY | 839.3 Million USD | 4.21% |
2013 Q3 | 830.69 Million USD | 1.04% |
2013 Q2 | 822.16 Million USD | -0.07% |
2013 Q4 | 839.3 Million USD | 1.04% |
2013 Q1 | 822.78 Million USD | 2.16% |
2012 Q4 | 805.4 Million USD | 1.03% |
2012 FY | 805.4 Million USD | -0.24% |
2012 Q3 | 797.16 Million USD | 1.03% |
2012 Q1 | 780.94 Million USD | -3.27% |
2012 Q2 | 789 Million USD | 1.03% |
2011 Q3 | 765.07 Million USD | 1.03% |
2011 Q4 | 807.36 Million USD | 5.53% |
2011 FY | 807.36 Million USD | 0.0% |
2011 Q2 | 757.27 Million USD | 16.13% |
2011 Q1 | 652.08 Million USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2008 Q2 | 14.88 Million USD | 0.0% |
2008 Q1 | - USD | -100.0% |
2008 FY | - USD | -100.0% |
2008 Q4 | - USD | -100.0% |
2008 Q3 | 460 Thousand USD | -96.91% |
2007 Q4 | 400 Million USD | 0.0% |
2007 Q3 | 400 Million USD | 0.0% |
2007 Q2 | 400 Million USD | -0.0% |
2007 Q1 | 400 Million USD | 0.0% |
2007 FY | 400 Million USD | 0.0% |
2006 FY | - USD | -100.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q2 | - USD | -100.0% |
2006 Q1 | 25 Thousand USD | -53.7% |
2005 FY | 54 Thousand USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q4 | 54 Thousand USD | 0.0% |
2004 Q1 | 24.89 Million USD | -0.42% |
2004 FY | - USD | -100.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | -100.0% |
2004 Q2 | 24.79 Million USD | -0.41% |
2003 Q4 | 24.99 Million USD | -0.36% |
2003 FY | 24.99 Million USD | -2.42% |
2003 Q1 | 25.27 Million USD | -1.35% |
2003 Q2 | 25.18 Million USD | -0.37% |
2003 Q3 | 25.09 Million USD | -0.36% |
2002 FY | 25.62 Million USD | 4242.37% |
2002 Q1 | 25.61 Million USD | 4242.2% |
2002 Q2 | 25.53 Million USD | -0.34% |
2002 Q4 | 25.62 Million USD | 0.66% |
2002 Q3 | 25.45 Million USD | -0.32% |
2001 Q1 | 816 Thousand USD | -7.96% |
2001 Q3 | 667.78 Thousand USD | -10.13% |
2001 FY | 590 Thousand USD | -33.46% |
2001 Q4 | 590 Thousand USD | -11.65% |
2001 Q2 | 743.08 Thousand USD | -8.94% |
2000 Q1 | - USD | 0.0% |
2000 Q4 | 886.62 Thousand USD | -7.16% |
2000 FY | 886.62 Thousand USD | 0.0% |
2000 Q3 | 955.01 Thousand USD | -6.49% |
2000 Q2 | 1.02 Million USD | 0.0% |
1999 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aclaris Therapeutics, Inc. | 3.07 Million USD | -48338.517% |
Applied DNA Sciences, Inc. | 739.16 Thousand USD | -201344.338% |
Aspira Women's Health Inc. | 1.43 Million USD | -104025.874% |
Biodesix, Inc. | 35.22 Million USD | -4127.111% |
BioNexus Gene Lab Corp. | 98.76 Thousand USD | -1507549.626% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -133028.529% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -133028.529% |
Bionano Genomics, Inc. | 7.17 Million USD | -20652.613% |
CareDx, Inc | 28.27 Million USD | -5165.577% |
Check-Cap Ltd. | - USD | -Infinity% |
Castle Biosciences, Inc. | 14.19 Million USD | -10387.393% |
DarioHealth Corp. | 24.59 Million USD | -5955.061% |
Exact Sciences Corporation | 2.47 Billion USD | 39.847% |
Fulgent Genetics, Inc. | 10.11 Million USD | -14626.535% |
Guardant Health, Inc. | 1.13 Billion USD | -30.618% |
ICON Public Limited Company | 3.66 Billion USD | 59.377% |
IDEXX Laboratories, Inc. | 622.88 Million USD | -139.05% |
Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -1830847.814% |
iSpecimen Inc. | 29.13 Thousand USD | -5111468.829% |
Standard BioTools Inc. | 3.98 Million USD | -37283.881% |
MDxHealth SA | 35.56 Million USD | -4086.818% |
23andMe Holding Co. | 67.84 Million USD | -2094.709% |
Medpace Holdings, Inc. | 142.12 Million USD | -947.691% |
Myriad Genetics, Inc. | 130.9 Million USD | -1037.51% |
Mainz Biomed B.V. | 2.19 Million USD | -67708.528% |
ENDRA Life Sciences Inc. | 192.06 Thousand USD | -775170.486% |
NeoGenomics, Inc. | 606.06 Million USD | -145.682% |
Neogen Corporation | 888.39 Million USD | -67.606% |
Inotiv, Inc. | 399.4 Million USD | -272.801% |
Natera, Inc. | 282.94 Million USD | -426.251% |
OpGen, Inc. | 2.02 Million USD | -73553.948% |
OPKO Health, Inc. | 222.03 Million USD | -570.618% |
Psychemedics Corporation | 945 Thousand USD | -157466.138% |
Prenetics Global Limited | 867.21 Thousand USD | -171599.06% |
Prenetics Global Limited | 867.21 Thousand USD | -171599.06% |
Precipio, Inc. | 106 Thousand USD | -1404616.981% |
Personalis, Inc. | 1.23 Million USD | -120564.506% |
RadNet, Inc. | 812.06 Million USD | -83.359% |
Sera Prognostics, Inc. | 840 Thousand USD | -177161.905% |
Sotera Health Company | 2.22 Billion USD | 33.039% |
Neuronetics, Inc. | 59.28 Million USD | -2411.681% |
Star Equity Holdings, Inc. | 1.14 Million USD | -129943.668% |
Star Equity Holdings, Inc. | 1.14 Million USD | -129943.668% |
Trinity Biotech plc | 54.65 Million USD | -2624.561% |
T2 Biosystems, Inc. | 6.59 Million USD | -22467.445% |
Twist Bioscience Corporation | 79.17 Million USD | -1780.692% |
Exagen Inc. | 19.23 Million USD | -7642.707% |